Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • New report, The participation equation, uncovers key drivers of patient engagement in clinical trials

    October 16, 2025 | Participant engagement, Patient Voice, clinical trials 

    Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.

    Report fan imager

    CAMBRIDGE, UK – October 16, 2025 – Healthcare communications agency Cuttsy+Cuttsy, in collaboration with the International Society for Patient Engagement Professionals (ISPEP), today announced the release of The participation equation, a comprehensive report exploring what drives participant engagement in modern clinical trials. The research offers a fresh, 360-degree perspective by combining quantitative data from 700 clinical trial participants, alongside in-depth qualitative interviews and industry leader insights.

    The report reveals a significant shift in how people discover clinical trials, with 45% of survey respondents learning about opportunities through social media. This highlights a growing reliance on patients to find trials independently, rather than through healthcare professionals. The findings suggest that while patients are taking charge of their health decisions, more can be done to create proactive and supportive pathways to trial participation.

    The participation equation also establishes a clear link between a participant’s trial experience and their likelihood of completing that trial. The data shows that trial completion rates increase in line with positive experience scores. A key factor in this is the level of support felt from the trial healthcare team; participants who said they ‘definitely’ felt supported had a 92% trial completion rate. The report further emphasises that ongoing and empathetic human connection in combination with high-quality and supportive resources are vital for retention.

    “This report brings forward the experiences of patients who have recently participated in modern trials reflective of today’s research landscape and the growing complexity in the trials landscape” says Alexandra Charge, CEO & Co-Founder of ISPEP. “Their insights go beyond ‘what happened’ to reveal ‘why it mattered’, highlighting where trial processes supported them and where gaps remain.”

    The research provides actionable insights for the industry, by providing credible evidence sources that are aligned with participant preferences to support and improve recruitment, retention, and data quality. By understanding how participants weigh burdens against benefits and what support they truly need, sponsors can move from patient-informed trials to truly patient-ready ones. The report is a call to action for the clinical research community to operationalise patient preference into trial design and delivery.

    Download The participation equation to learn more about the evolving landscape of patient engagement and discover how to better align trial processes with patient needs.

    The full report is available to download here.

    This content was provided by Cuttsy + Cuttsy

    Company Details

    Cuttsy and Cuttsy Logo

    Cuttsy + Cuttsy

    Email
    Website

     Latest Content from  Cuttsy + Cuttsy 

    Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People

    Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.

    Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating

    Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering...

    Age is not just a number when it comes to clinical trials

    In this blog we look at the critical underrepresentation of older adults in clinical trials, emphasising the need for inclusive trial designs and targeted strategies to ensure safe and effective...

    How to boost clinical trial access and make patients health-empowered

    Clinical research is becoming more patient-centric, but there's still more that needs to be done to make clinical trials available to everyone. This could include wider participation.

    Closing the loop: Why clinical trial results matter to participants

    Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.

    Unveiling the truth: A journey into women’s representation in clinical trials

    We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.

    Clarity in clinical trials

    Discover how transparent, empathetic communication and health literacy principles can empower patients and enhance engagement in clinical trials, transforming participants into active partners in their healthcare journey.

    Caring for patients’ mental health in clinical trials

    We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.

    Driving equitable healthcare: The role of DE&I in clinical trials

    Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...

    Empowering patients through more accessible clinical trial information

    Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...